3-hydroxybutyric acid and 1-methyl-4-phenylpyridinium

3-hydroxybutyric acid has been researched along with 1-methyl-4-phenylpyridinium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Clarke, K; Kashiwaya, Y; Mori, N; Nakashima, K; Takeshima, T; Veech, RL1
Gao, Y; Gao, Z; Han, G; Jiang, Z; Li, F; Wang, M; Wang, Y; Wang, Z; Yin, X1

Other Studies

2 other study(ies) available for 3-hydroxybutyric acid and 1-methyl-4-phenylpyridinium

ArticleYear
D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, May-09, Volume: 97, Issue:10

    Topics: 1-Methyl-4-phenylpyridinium; 3-Hydroxybutyric Acid; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cells, Cultured; Culture Media, Serum-Free; Embryo, Mammalian; Hippocampus; Humans; Ketone Bodies; Mesencephalon; Microtubule-Associated Proteins; Models, Neurological; Neurons; Parkinson Disease; Peptide Fragments; Rats; Tyrosine 3-Monooxygenase

2000
β-Hydroxybutyrate alleviates pyroptosis in MPP
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3-Hydroxybutyric Acid; Animals; Cytokines; Ketone Bodies; Mice; Neurodegenerative Diseases; NLR Family, Pyrin Domain-Containing 3 Protein; Parkinson Disease; Pyroptosis

2022